CHRISTOPHER MOYER

Monitored the CARES "Coronavirus Aid, Relief and Economic Security Act" and interim supplemental relief packages. Monitored HR 1600, the "HEROES Act" and Medicare accelerated payments program provisions.

Monitored the CARES "Coronavirus Aid, Relief and Economic Security Act" and the Emergency Appropriations for Coronavirus Health Response and Agency Operations. Monitored HR 5826, "Consumer Protections Against Surprise medical Bills Act of 2020."

Monitored the introduction of drug pricing legislation (HR 3) for its potential impact on existing and emerging cancer drug therapies and site neutrality. Monitored Medicare reimbursement developments in the agencies and Congress for alternative cancer therapies such as CAR-T. Reviewed HR 3235, Access to Genetic Counselor Services Act and HR 1948, Lymphedema Treatment Act for potential support.

Monitored the introduction of drug pricing legislation for its potential impact on existing and emerging cancer drug therapies and site neutrality. Monitored Medicare reimbursement developments in the agencies and Congress for alternative cancer therapies such as CAR-T.

The President's FY 2020 Budget as it relates to site neutral payment policies and funding for the National Institutes of Health, monitored the introduction of drug pricing legislation for its potential impact on existing and emerging cancer drug therapies. Monitored Medicare reimbursement developments in the agencies and Congress for alternative cancer therapies such as CAR-T.

The President's FY 2020 Budget as it relates to site neutral payment policies and funding for the National Institutes of Health, monitored the introduction of drug pricing legislation for its potential impact on existing and emerging cancer drug therapies.

FY 2018 Continuing Resolution, budget agreement, the omnibus FY 2018 appropriations bill and the President's FY 2019 Budget as they relate to site neutral payment policies and funding for the National Institutes of Health.

FY 2018 Continuing Resolution, budget agreement, the omnibus FY 2018 appropriations bill and the President's FY 2019 Budget as they relate to site neutral payment policies and funding for the National Institutes of Health.

FY 2018 Continuing Resolution, budget agreement, the omnibus FY 2018 appropriations bill and the President's FY 2019 Budget as they relate to site neutral payment policies and funding for the National Institutes of Health.

FY 2018 Continuing Resolution, budget agreement, the omnibus FY 2018 appropriations bill and the President's FY 2019 Budget as they relate to site neutral payment policies and funding for the National Institutes of Health.

American Health Care Act, Better Care Reconciliation Act, Obamacare Repeal Reconciliation Act and the Tax Cuts & Jobs Act as they relate to patient access and affordability to specialized cancer treatment and the adequacy of provider networks.

American Health Care Act, Better Care Reconciliation Act and Obamacare Repeal Reconciliation Act as they relate to patient access and affordability to specialized cancer treatment and the adequacy of provider networks.

American Health Care Act as it relates to patient access and affordability to specialized cancer treatment and the adequacy of provider networks.

American Health Care Act as it relates to patient access and affordability to specialized cancer treatment and the adequacy of provider networks.

21st Century Cures Act to include language of Section 202 of H. R. 5273, the Helping Hospitals Improve Patient Care Act of 2016 to exempt dedicated cancer centers from the site-neutral payment changes enacted by 603 of the Bipartisan Budget Act of 2015.

Section 202 of H. R. 5273, the Helping Hospitals Improve Patient Care Act of 2016 to exempt dedicated cancer centers from the site-neutral payment changes enacted by 603 of the Bipartisan Budget Act of 2015.

Section 202 of H. R. 5273, the Helping Hospitals Improve Patient Care Act of 2016 to exempt dedicated cancer centers from the site-neutral payment changes enacted by 603 of the Bipartisan Budget Act of 2015.

Section 603 of the Bipartisan Budget Act of 2015 regarding changes in payments to hospital outpatient departments

SGR Repeal & Medicare Beneficiary Access Improvement Act of 2013

HR 2869, the proposed Medicare Patient Access to Cancer Treatment Act 0f 2013, that would equalize Medicare reimbursements for cancer services between hospital outpatient departments and physician offices.

BUD - NIH/NCI budget; HCR - cancer; INS - health insurance exchanges; MED - clinical trials; MMM - payment rates

BUD - NIH/NCI budget; HCR - cancer; INS - health insurance exchanges; MED - clinical trials; MMM - payment rates

BUD - NIH/NCI budget; HCR - cancer; INS - health insurance exchanges; MED - clinical trials; MMM - payment rates